Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings

被引：0
|
作者：
Islam, Mahnoor [1 ]
机构：
[1] Dow Med Coll, Baba E Urdu Rd, Karachi, Pakistan
来源：
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2020年 / 30卷 / 06期
关键词：
EFFICACY;
D O I：
10.29271/jcpsp.2020.Supp2.S78
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [31] Improving Hospital Oxygen Systems for COVID-19 in Low-Resource Settings: Lessons From the Field
    Graham, Hamish R.
    Bagayana, Sheillah M.
    Bakare, Ayobami A.
    Olayo, Bernard O.
    Peterson, Stefan S.
    Duke, Trevor
    Falade, Adegoke G.
    GLOBAL HEALTH-SCIENCE AND PRACTICE, 2020, 8 (04): : 858 - 862
  • [32] Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19
    Zou, Li
    Dai, Lijun
    Zhang, Xingyu
    Zhang, Zhaohui
    Zhang, Zhentao
    ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (08) : 765 - 772
  • [33] Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
    Gevers, S.
    Kwa, M. S. G.
    Wijnans, E.
    van Nieuwkoop, C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (09) : 1276 - 1277
  • [34] Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
    Carafoli, Ernesto
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 538 : 156 - 162
  • [35] Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
    Bahadoram, Mohammad
    Keikhaei, Bijan
    Saeedi-Boroujeni, Ali
    Mahmoudian-Sani, Mohammad-Reza
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (05) : 997 - 1001
  • [36] Chloroquine and hydroxychloroquine increase risk of death in COVID-19
    Reactions Weekly, 2020, 1806 (1) : 1 - 1
  • [37] Chloroquine and hydroxychloroquine for COVID-19:Perspectives on their failure in repurposing
    Shah, Rashmi R.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (01) : 17 - 27
  • [38] Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
    Mohammad Bahadoram
    Bijan Keikhaei
    Ali Saeedi-Boroujeni
    Mohammad-Reza Mahmoudian-Sani
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, 394 : 997 - 1001
  • [39] Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety
    Jeevaratnam, Kamalan
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (04) : 256 - 257
  • [40] Emergency Approval of Chloroquine and Hydroxychloroquine for Treatment of COVID-19
    Piszczatoski, Christopher R.
    Powell, Jason
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (08) : 827 - 831
12345